Cargando…

Retrospective Analysis of Clinical Genetic Testing in Pediatric Primary Dilated Cardiomyopathy: Testing Outcomes and the Effects of Variant Reclassification

BACKGROUND: Genetic testing in pediatric primary dilated cardiomyopathy (DCM) patients has identified numerous disease‐causing variants, but few studies have evaluated genetic testing outcomes in this population in the context of patient and familial clinical data or assessed the clinical implicatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quiat, Daniel, Witkowski, Leora, Zouk, Hana, Daly, Kevin P., Roberts, Amy E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428992/ https://www.ncbi.nlm.nih.gov/pubmed/32458740 http://dx.doi.org/10.1161/JAHA.120.016195

Ejemplares similares

Pediatric Primary Dilated Cardiomyopathy Gene Testing and Variant Reclassification: Does It Matter?
por: Towbin, Jeffrey A.
Publicado: (2020)

The Role of Genetic Testing in the Evaluation of Dilated Cardiomyopathies
por: Agboola, Kolade M., et al.
Publicado: (2021)

Clinical Implication of Genetic Testing in Dilated Cardiomyopathy
por: Lee, Ju-Hee, et al.
Publicado: (2021)

Patient perspectives on variant reclassification after cancer susceptibility testing
por: Halverson, Colin M. E., et al.
Publicado: (2020)

Clinical utility of genetic tests for inherited hypertrophic and dilated cardiomyopathies
por: Colombo, Maria Giovanna, et al.
Publicado: (2008)

Rare Variants Associated with Arrhythmogenic Cardiomyopathy: Reclassification Five Years Later
por: Vallverdú-Prats, Marta, et al.
Publicado: (2021)

Importance of Genetic Testing in Dilated Cardiomyopathy: Applications and Challenges in Clinical Practice
por: Lamounier Júnior, Arsonval, et al.
Publicado: (2019)

How should we address the inevitable harms from non‐negligent variant reclassification in predictive genetic testing?
por: Rashkin, Misha, et al.
Publicado: (2022)

Reclassification of genetic variants in children with long QT syndrome
por: Westphal, Dominik S., et al.
Publicado: (2020)

Genetic Test for Dilated and Hypertrophic Cardiomyopathies: Useful or Less Than Useful for Patients?
por: Pastore, F, et al.
Publicado: (2013)

Molecular Reclassification of Crohn's Disease by Cluster Analysis of Genetic Variants
por: Cleynen, Isabelle, et al.
Publicado: (2010)

Pathogenic Variants Associated With Dilated Cardiomyopathy Predict Outcome in Pediatric Myocarditis
por: Seidel, Franziska, et al.
Publicado: (2021)

Genetic epidemiology of titin-truncating variants in the etiology of dilated cardiomyopathy
por: Tabish, Ali M., et al.
Publicado: (2017)

The Multifaced Perspectives of Genetic Testing in Pediatric Cardiomyopathies and Channelopathies
por: Popa-Fotea, Nicoleta-Monica, et al.
Publicado: (2020)

Whole-Genome Sequencing as a First-Line Genetic Test in Familial Dilated Cardiomyopathy
por: Minoche, Andre E., et al.
Publicado: (2018)

Diagnostic yield and predictive value on left ventricular remodelling of genetic testing in dilated cardiomyopathy
por: Bertero, Edoardo, et al.
Publicado: (2023)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

The Genetic Evaluation of Dilated Cardiomyopathy
por: Bui, Quan M., et al.
Publicado: (2023)

Reanalysis and reclassification of rare genetic variants associated with inherited arrhythmogenic syndromes
por: Campuzano, Oscar, et al.
Publicado: (2020)

Myocardial ultrastructure can augment genetic testing for sporadic dilated cardiomyopathy with initial heart failure
por: Saito, Tsunenori, et al.
Publicado: (2021)

Genetic Burden of TNNI3K in Diagnostic Testing of Patients With Dilated Cardiomyopathy and Supraventricular Arrhythmias
por: Pham, Caroline, et al.
Publicado: (2023)

Retrospective study of dilated cardiomyopathy in dogs
por: Freid, Kimberly J., et al.
Publicado: (2020)

Genotype and Cardiac Outcomes in Pediatric Dilated Cardiomyopathy
por: Khan, Rabia S., et al.
Publicado: (2021)

Role of Titin Missense Variants in Dilated Cardiomyopathy
por: Begay, Rene L., et al.
Publicado: (2015)

Genetics of Human and Canine Dilated Cardiomyopathy
por: Simpson, Siobhan, et al.
Publicado: (2015)

Systematic permutation testing in GWAS pathway analyses: identification of genetic networks in dilated cardiomyopathy and ulcerative colitis
por: Backes, Christina, et al.
Publicado: (2014)

A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy
por: Catchpool, Max, et al.
Publicado: (2019)

The addition of genetic testing and cardiovascular magnetic resonance to routine clinical data for stratification of etiology in dilated cardiomyopathy
por: Amin, Ravi J., et al.
Publicado: (2022)

Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy
por: Mazzarotto, Francesco, et al.
Publicado: (2020)

Genetic testing in specific cardiomyopathies
por: Haugaa, Kristina Hermann, et al.
Publicado: (2009)

Pathogenic Roles of Cardiac Fibroblasts in Pediatric Dilated Cardiomyopathy
por: Tsuru, Hirofumi, et al.
Publicado: (2023)

Genetic Variants Are Not Rare in ICD Candidates with Dilated Cardiomyopathy: Time for Next-Generation Sequencing?
por: Sousa, Alexandra, et al.
Publicado: (2019)

Genetic variants in Chinese patients with sporadic dilated cardiomyopathy: a cross-sectional study
por: Shen, Cheng, et al.
Publicado: (2022)

Genetic Variations Leading to Familial Dilated Cardiomyopathy
por: Cho, Kae Won, et al.
Publicado: (2016)

Clinical Implications of the Genetic Architecture of Dilated Cardiomyopathy
por: Wilsbacher, Lisa D.
Publicado: (2020)

The Genetic Pathways Underlying Immunotherapy in Dilated Cardiomyopathy
por: Kadhi, Ayat, et al.
Publicado: (2021)

Determining the Likelihood of Disease Pathogenicity Among Incidentally Identified Genetic Variants in Rare Dilated Cardiomyopathy‐Associated Genes
por: Yang, Qixin, et al.
Publicado: (2022)

Clinical genetic testing in four highly suspected pediatric restrictive cardiomyopathy cases
por: Zheng, Min, et al.
Publicado: (2022)

Genetic variations of β-MYH7 in hypertrophic cardiomyopathy and dilated cardiomyopathy
por: Tanjore, Reena, et al.
Publicado: (2010)

Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy
por: Wasielewski, Marijke, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v751go5jktdhfrov0b99e691mb